✦ LIBER ✦

Treatment choices for managing hyperglycaemia in patients with type 2 diabetes and moderate to severe renal disease

✍ Scribed by F. Palmer; S.L. Prior; A. Mallipedhi; D.A. Jones; D.E. Price; J.W. Stephens

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Linagliptin treatment in subjects with t

✍ Groop, P.-H.; Del Prato, S.; Taskinen, M.-R.; Owens, D. R.; Gong, Y.; Crowe, S.; 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 668 KB

One-year safety, tolerability and effica

✍ W. Kothny; Q. Shao; P.-H. Groop; V. Lukashevich 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 586 KB

Irbesartan approved in Canada for renal

📂 Article 📅 2002 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Angiotensin-converting enzyme inhibition

✍ Rita Pradhan; Donald Fong; Cabrini March; Robert Jack; Ghodratala Rezapour; Keit 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 81 KB

Rosiglitazone added to a sulphonylurea:

✍ Arvind Agrawal; Nigel P Jones; Maureen C Sautter 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 141 KB

PCV47 DIRECT MEDICAL COSTS FOR TREATMENT

✍ P Berto; G Cremonesi 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB